Biorestorative Therapies (BRTX) Competitors $1.62 -0.05 (-2.99%) Closing price 04:00 PM EasternExtended Trading$1.58 -0.04 (-2.16%) As of 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BRTX vs. BMGL, CCM, MRAI, MGRX, BGLC, KDLY, ACON, NIVF, DHAC, and BACKShould you be buying Biorestorative Therapies stock or one of its competitors? The main competitors of Biorestorative Therapies include Basel Medical Group (BMGL), Concord Medical Services (CCM), Marpai (MRAI), Mangoceuticals (MGRX), BioNexus Gene Lab (BGLC), Kindly MD (KDLY), Aclarion (ACON), NewGenIvf Group (NIVF), Digital Health Acquisition (DHAC), and IMAC (BACK). These companies are all part of the "healthcare" industry. Biorestorative Therapies vs. Its Competitors Basel Medical Group Concord Medical Services Marpai Mangoceuticals BioNexus Gene Lab Kindly MD Aclarion NewGenIvf Group Digital Health Acquisition IMAC Basel Medical Group (NASDAQ:BMGL) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations. Which has better earnings and valuation, BMGL or BRTX? Basel Medical Group has higher earnings, but lower revenue than Biorestorative Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/ABiorestorative Therapies$605.20K21.36-$8.98M-$1.27-1.28 Do institutionals & insiders believe in BMGL or BRTX? 69.4% of Biorestorative Therapies shares are held by institutional investors. 30.8% of Biorestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Do analysts rate BMGL or BRTX? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is BMGL or BRTX more profitable? Basel Medical Group has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -1,772.40%. Basel Medical Group's return on equity of 0.00% beat Biorestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A Biorestorative Therapies -1,772.40%-137.00%-88.31% Does the media prefer BMGL or BRTX? In the previous week, Biorestorative Therapies had 2 more articles in the media than Basel Medical Group. MarketBeat recorded 4 mentions for Biorestorative Therapies and 2 mentions for Basel Medical Group. Basel Medical Group's average media sentiment score of 0.95 beat Biorestorative Therapies' score of 0.47 indicating that Basel Medical Group is being referred to more favorably in the media. Company Overall Sentiment Basel Medical Group Positive Biorestorative Therapies Neutral SummaryBasel Medical Group and Biorestorative Therapies tied by winning 4 of the 8 factors compared between the two stocks. Get Biorestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRTX vs. The Competition Export to ExcelMetricBiorestorative TherapiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.92M$3.31B$6.01B$10.23BDividend YieldN/A2.29%5.66%4.69%P/E Ratio-1.2822.1185.3526.57Price / Sales21.36420.49583.22179.26Price / CashN/A47.1938.3262.20Price / Book1.3210.2112.726.53Net Income-$8.98M-$52.40M$3.30B$275.96M7 Day Performance8.00%0.88%1.05%-1.40%1 Month Performance3.18%12.35%7.56%5.16%1 Year Performance-2.89%30.13%79.69%31.55% Biorestorative Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRTXBiorestorative Therapies2.2139 of 5 stars$1.62-3.0%N/A+3.1%$13.32M$400K0.007Analyst ForecastGap UpBMGLBasel Medical GroupN/A$1.82+1.7%N/AN/A$33.03MN/A0.0036Analyst ForecastCCMConcord Medical Services0.6986 of 5 stars$6.13-6.7%N/A-18.4%$28.52M$52.60M0.00970Analyst ForecastGap DownMRAIMarpaiN/A$1.36+3.8%N/A+111.3%$24.90M$34.87M-0.52150High Trading VolumeMGRXMangoceuticals1.5172 of 5 stars$2.19+3.8%N/A-95.5%$22.23M$620K-0.573Analyst ForecastGap UpBGLCBioNexus Gene Lab0.2103 of 5 stars$5.47flatN/A+31.2%$9.83M$9.51M0.0030Analyst ForecastKDLYKindly MDN/A$1.17+1.7%N/A-29.9%$7.05M$2.47M-1.52N/AGap UpHigh Trading VolumeACONAclarion1.759 of 5 stars$7.50-1.7%$11,758.50+156,680.0%-99.5%$4.44M$50K0.007Positive NewsAnalyst ForecastNIVFNewGenIvf GroupN/A$1.79-1.1%N/A-99.7%$3.90M$5.43M0.00N/ANews CoveragePositive NewsAnalyst ForecastDHACDigital Health AcquisitionN/A$0.63-1.4%N/A-45.9%$2.26MN/A0.002,021BACKIMACN/A$0.07-2.8%N/A-93.4%$145K$72.05K0.00180News Coverage Related Companies and Tools Related Companies Basel Medical Group Competitors Concord Medical Services Competitors Marpai Competitors Mangoceuticals Competitors BioNexus Gene Lab Competitors Kindly MD Competitors Aclarion Competitors NewGenIvf Group Competitors Digital Health Acquisition Competitors IMAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BRTX) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBig Oil Firm Stakes $1 Billion in Startup That Could Kill Big OilOn September 22, the unthinkable happened... One of the world's biggest oil producers poured $1 billion int...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biorestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biorestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
